Carol Phd Ocleireacain - Net Worth and Insider Trading

Carol Phd Ocleireacain Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Carol Phd Ocleireacain owns 1 companies in total, including Spectrum Pharmaceuticals Inc (SPPI) .

Click here to see the complete history of Carol Phd Ocleireacain’s form 4 insider trades.

Insider Ownership Summary of Carol Phd Ocleireacain

Ticker Company Transaction Date Type of Owner
SPPI Spectrum Pharmaceuticals Inc 2003-07-31 director

Carol Phd Ocleireacain Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Carol Phd Ocleireacain Ownership Network

Ownership Network List of Carol Phd Ocleireacain

No Data

Ownership Network Relation of Carol Phd Ocleireacain

Insider Network Chart


Carol Phd Ocleireacain Owned Company Details

What does Spectrum Pharmaceuticals Inc do?

Who are the key executives at Spectrum Pharmaceuticals Inc?

Carol Phd Ocleireacain is the director of Spectrum Pharmaceuticals Inc. Other key executives at Spectrum Pharmaceuticals Inc include See Remarks Nora Brennan , Chief Legal Officer Keith M Mcgahan , and director & CEO & President Thomas J Riga .

Spectrum Pharmaceuticals Inc (SPPI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Spectrum Pharmaceuticals Inc (SPPI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Spectrum Pharmaceuticals Inc (SPPI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Spectrum Pharmaceuticals Inc (SPPI)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Spectrum Pharmaceuticals Inc Insider Transactions

No Available Data

Carol Phd Ocleireacain Mailing Address

Above is the net worth, insider trading, and ownership report for Carol Phd Ocleireacain. Currently GuruFocus does not have mailing address information for Carol Phd Ocleireacain.